1. May R, Thurner J. 1957; The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 8:419–27. doi: 10.1177/000331975700800505. DOI:
10.1177/000331975700800505. PMID:
13478912.
Article
2. Harbin MM, Lutsey PL. 2020; May-Thurner syndrome: history of understanding and need for defining population prevalence. J Thromb Haemost. 18:534–42. doi: 10.1111/jth.14707. DOI:
10.1111/jth.14707. PMID:
31821707.
Article
6. Wu WL, Tzeng WS, Wu RH, Tsai WL, Chen MC, Lin PC, et al. 2012; Comprehensive MDCT evaluation of patients with suspected May-Thurner syndrome. AJR Am J Roentgenol. 199:W638–45. doi: 10.2214/AJR.11.8040. DOI:
10.2214/AJR.11.8040. PMID:
23096209.
Article
8. Park JY, Ahn JH, Jeon YS, Cho SG, Kim JY, Hong KC. 2014; Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May-Thurner syndrome. Phlebology. 29:461–70. doi: 10.1177/0268355513491724. DOI:
10.1177/0268355513491724. PMID:
23761876.
Article
9. Vedantham S, Millward SF, Cardella JF, Hofmann LV, Razavi MK, Grassi CJ, et al. 2006; Society of Interventional Radiology. Society of Interventional Radiology position statement: treatment of acute iliofemoral deep vein thrombosis with use of adjunctive catheter-directed intrathrombus thrombolysis. J Vasc Interv Radiol. 17:613–6. doi: 10.1097/01.RVI.0000203802.35689.66. DOI:
10.1097/01.RVI.0000203802.35689.66. PMID:
16614142.
Article
10. Tsai CJ, Lee CY. 2019; Comparative outcomes of catheter-directed thrombolysis plus rivaroxaban vs rivaroxaban alone in patients with acute iliofemoral deep vein thrombosis. J Chin Med Assoc. 82:902–8. doi: 10.1097/JCMA.0000000000000206. DOI:
10.1097/JCMA.0000000000000206. PMID:
31567881.
Article